AI and Autonomy SimBioSys gets FDA nod for AI breast cancer platform The platform's latest update represents the next evolution of a clinically validated platform designed to improve consistency, precision, and efficiency Joseph Morton2 days ago
AI and Autonomy The dual nature of artificial intelligence: A Mugglehead roundup AI is not inherently good or bad—it is a tool, shaped by how we choose to use it Joseph MortonJune 20, 2025
Health & Wellness Quest Diagnostics and University of Texas want to promote more cancer screenings Quest plans to refine, expand, and validate the MCaST technology for its own lab-developed test Joseph MortonJune 11, 2025
Medical and Pharmaceutical Against the rise of early onset cancer: a Mugglehead roundup Cancer treatment markets are set to expand rapidly over the next decade Joseph MortonMay 29, 2025
Medical and Pharmaceutical Lucid Diagnostics joins Russell 2000 and 3000 indexes Investment managers and institutional investors widely use the Russell indexes for both index funds and active investment benchmarks Joseph MortonMay 27, 2025